Advanced gastroesophageal adenocarcinoma (GEA) with HER2 positivity has long presented significant treatment challenges, with first-line therapies offering limited survival benefits despite advances ...
CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus ...
WASHINGTON (Valley News Live) - The Senate passed bipartisan legislation that would expand federal benefits for families of firefighters and first responders who die or become permanently disabled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results